CytomX Therapeutics: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — CytomX Therapeutics Inc. (CTMX) on Tuesday reported a loss of $1.1 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 2 cents.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The biopharmaceutical company posted revenue of $24.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $17.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTMX at https://www.zacks.com/ap/CTMX
